[Treatment of malignant otitis externa]. 1990

M González Ortín, and E López Meseguer, and A Estaca Jiménez, and C Sprekelsen Gassó, and L González Sicilia
Hospital General de Murcia, Departamento de Otorrinolaringologia, Facultad de Medicina, Universidad de Murcia.

Though rare the malignant otitis externa must be borne in mind because in its precocious diagnosis is based the success of the management. Elderly people, diabetics and immunodepressed are especially exposed. The CAT is basic in order to detect the spreading of the process. The patient being admitted at a Medical center, the antibiotherapy started at once with Ceftazidine, 2 g every 12 hours via i.v. The exeresis of the e.e.ca proves sometimes necessary after control of the infection. This procedure assures the healing and prevent the recurrences some times seen. But when infection disappears owing to the success of the antibiotherapy in 2-3 weeks; the culture for Pseudomonas is negative 3 weeks later; and the previous CAT showed no spreading to the tympanal bone, the surgery must be discarded. The process is considered over when the culture for Pseudomonas aeruginosa is negative, but review of the patients is compulsory at least during half a year.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010032 Otitis Externa Inflammation of the OUTER EAR including the external EAR CANAL, cartilages of the auricle (EAR CARTILAGE), and the TYMPANIC MEMBRANE. External Ear Inflammation,External Otitis,Ear Inflammation, External,Externa, Otitis,External Ear Inflammations,External Otitides,Inflammation, External Ear,Otitides, External,Otitis, External
D011552 Pseudomonas Infections Infections with bacteria of the genus PSEUDOMONAS. Infections, Pseudomonas,Pseudomonas aeruginosa Infection,Infection, Pseudomonas,Pseudomonas Infection,Pseudomonas aeruginosa Infections
D003131 Combined Modality Therapy The treatment of a disease or condition by several different means simultaneously or sequentially. Chemoimmunotherapy, RADIOIMMUNOTHERAPY, chemoradiotherapy, cryochemotherapy, and SALVAGE THERAPY are seen most frequently, but their combinations with each other and surgery are also used. Multimodal Treatment,Therapy, Combined Modality,Combined Modality Therapies,Modality Therapies, Combined,Modality Therapy, Combined,Multimodal Treatments,Therapies, Combined Modality,Treatment, Multimodal,Treatments, Multimodal
D003922 Diabetes Mellitus, Type 1 A subtype of DIABETES MELLITUS that is characterized by INSULIN deficiency. It is manifested by the sudden onset of severe HYPERGLYCEMIA, rapid progression to DIABETIC KETOACIDOSIS, and DEATH unless treated with insulin. The disease may occur at any age, but is most common in childhood or adolescence. Diabetes Mellitus, Brittle,Diabetes Mellitus, Insulin-Dependent,Diabetes Mellitus, Juvenile-Onset,Diabetes Mellitus, Ketosis-Prone,Diabetes Mellitus, Sudden-Onset,Diabetes, Autoimmune,IDDM,Autoimmune Diabetes,Diabetes Mellitus, Insulin-Dependent, 1,Diabetes Mellitus, Type I,Insulin-Dependent Diabetes Mellitus 1,Juvenile-Onset Diabetes,Type 1 Diabetes,Type 1 Diabetes Mellitus,Brittle Diabetes Mellitus,Diabetes Mellitus, Insulin Dependent,Diabetes Mellitus, Juvenile Onset,Diabetes Mellitus, Ketosis Prone,Diabetes Mellitus, Sudden Onset,Diabetes, Juvenile-Onset,Diabetes, Type 1,Insulin Dependent Diabetes Mellitus 1,Insulin-Dependent Diabetes Mellitus,Juvenile Onset Diabetes,Juvenile-Onset Diabetes Mellitus,Ketosis-Prone Diabetes Mellitus,Sudden-Onset Diabetes Mellitus
D004359 Drug Therapy, Combination Therapy with two or more separate preparations given for a combined effect. Combination Chemotherapy,Polychemotherapy,Chemotherapy, Combination,Combination Drug Therapy,Drug Polytherapy,Therapy, Combination Drug,Chemotherapies, Combination,Combination Chemotherapies,Combination Drug Therapies,Drug Polytherapies,Drug Therapies, Combination,Polychemotherapies,Polytherapies, Drug,Polytherapy, Drug,Therapies, Combination Drug
D005260 Female Females
D006099 Granuloma A relatively small nodular inflammatory lesion containing grouped mononuclear phagocytes, caused by infectious and noninfectious agents. Granulomas
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

M González Ortín, and E López Meseguer, and A Estaca Jiménez, and C Sprekelsen Gassó, and L González Sicilia
April 1990, Nederlands tijdschrift voor geneeskunde,
M González Ortín, and E López Meseguer, and A Estaca Jiménez, and C Sprekelsen Gassó, and L González Sicilia
November 2012, The Journal of craniofacial surgery,
M González Ortín, and E López Meseguer, and A Estaca Jiménez, and C Sprekelsen Gassó, and L González Sicilia
June 2008, Otolaryngologic clinics of North America,
M González Ortín, and E López Meseguer, and A Estaca Jiménez, and C Sprekelsen Gassó, and L González Sicilia
September 1978, The Journal of laryngology and otology,
M González Ortín, and E López Meseguer, and A Estaca Jiménez, and C Sprekelsen Gassó, and L González Sicilia
February 2010, Indian pediatrics,
M González Ortín, and E López Meseguer, and A Estaca Jiménez, and C Sprekelsen Gassó, and L González Sicilia
February 1986, British medical journal (Clinical research ed.),
M González Ortín, and E López Meseguer, and A Estaca Jiménez, and C Sprekelsen Gassó, and L González Sicilia
January 1986, Acta oto-rhino-laryngologica Belgica,
M González Ortín, and E López Meseguer, and A Estaca Jiménez, and C Sprekelsen Gassó, and L González Sicilia
January 2007, Brazilian journal of otorhinolaryngology,
M González Ortín, and E López Meseguer, and A Estaca Jiménez, and C Sprekelsen Gassó, and L González Sicilia
January 2015, Ear, nose, & throat journal,
M González Ortín, and E López Meseguer, and A Estaca Jiménez, and C Sprekelsen Gassó, and L González Sicilia
April 1979, Revista clinica espanola,
Copied contents to your clipboard!